| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $8.1M | -11.3% |
| Cost of Revenue | $5.2M | -32.1% |
| Gross Profit | $2.9M | +100.3% |
| R&D Expense | $115K | -69.9% |
| SG&A Expense | $2.7M | -24.1% |
| Net Income | -$2.8M | +54.6% |
| EPS (Basic) | -$0.21 | +56.3% |
| EPS (Diluted) | -$0.21 | +55.3% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Accounts Receivable | $821K | +551.6% |
| Inventory | $1.2M | +15.8% |
| Current Assets | $4.2M | -5.0% |
| Total Assets | $4.8M | -5.6% |
| Current Liabilities | $2.3M | -10.3% |
| Total Liabilities | $2.3M | -10.3% |
| Stockholders' Equity | $2.5M | -0.7% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.0M | -11.7% |
| Capital Expenditures | $13K | +0.0% |
| Investing Cash Flow | -$13K | +0.0% |
| Financing Cash Flow | $1.8M | — |
| Free Cash Flow | -$3.0M | -11.6% |